Earningsreport

Q3/2019 9/30/2019 EPS -0.020 ZacksConsensus N/A ActVsEst N/A - N/A

NovaBay Pharmaceuticals, Inc.  (NBY) 
NASDAQ:AMEX Investor Relations: novabay.com/investors